An interventional study of CAS + Intravascular measuring the pressure gradient and CAS (standard) in Carotid Artery Stenosis, Carotid Artery Stenting and Stroke, sponsored by 4th Military Clinical Hospital with Polyclinic, Poland. Not yet recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-07.
Sponsored by 4th Military Clinical Hospital with Polyclinic, Poland · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Carotid Stenosis with a site in Poland — 4 open to participants now, 6 under way, none of them phase 3. Carotid Stenosis · Poland.
Among the 10 studies in Carotid Stenosis with a site in Poland, this one is the only one that started in 2024, is one of 5 with no phase, and was the 10th registered.
369 studies on the registry are indexed under Carotid Stenosis; 88 are open to participants now.
Browse Carotid Stenosis studies →4 of the 10 studies in Carotid Stenosis with a site in Poland are open now. Recruiting first, the newest first:
John Paul II Hospital, Krakow · Sites in Poland
Ages 18+
John Paul II Hospital, Krakow · Sites in Poland
Ages 18+
John Paul II Hospital, Krakow · Sites in Poland
Ages 18+
A study can be open while its sites in Poland have not opened yet or have stopped. Only those recruiting at a site in Poland →
Of the 62 Carotid Stenosis studies recruiting now, 39 (63%) set no upper age limit and none (0%) stop at 75 or younger; 4 take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2024.
This study's planned enrollment of 200 is above the median of 102 across 192 interventional studies indexed under Carotid Stenosis.
Median enrollment 259 across the 6 interventional studies, 175 across the 4 observational. Of the 3 that completed or were terminated, 1 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 10 have an industry lead sponsor. The 8 most frequent:
4th Military Clinical Hospital with Polyclinic, Poland is the lead sponsor of 10 studies on the registry; 8 are open to participants now.
4th Military Clinical Hospital with Polyclinic, Poland has 1 study filed under Carotid Stenosis — fewer than ten, so there is no comparison to draw.
1 of the studies in Carotid Stenosis with a site in Poland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT061237674th Military Clinical Hospital with Polyclinic, PolandInnovative Application of Pressure Gradient Measurement in Internal Carotid Stenosis in Patients Undergoing CAS | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Carotid Stenosis with a site in Poland, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
About 20% of stroke causes are atherosclerotic strokes caused by carotid artery stenosis.
In 2005, 92% of carotid artery interventions in the USA were performed in asymptomatic patients. It should be noted that screening in the general population for carotid artery disease is unwarranted, due to uncertain eligibility criteria for interventional treatment of asymptomatic patients. On the other hand, 10-15% of all patients with a first-ever stroke will experience an ischemic stroke as a result of previously untreated, asymptomatic, significant carotid artery stenosis.
Carotid artery angioplasty with stent placement (CAS) has become the second method of revascularization. ed, however, there is a great deal of ambiguity in the application of these criteria, which stems from the ratio of the risk to the possible benefit to the patient of performing the procedure, as well as the cost-effectiveness for health care systems.
OBJECTIVES The overall goal is (following the model of measuring fractional flow reserve - FFR) to try to establish a new parameter that could prove helpful in qualifying patients for percutaneous internal carotid artery angioplasty with stent implantation (CAS). Determining whether measuring the pressure gradient across the stenosis will determine which patients will benefit from the CAS procedure. In the absence of convincing evidence on the effects of CAS, especially for so-called asymptomatic patients, it is advisable to establish a parameter that would complement the eligibility criteria that, on the one hand, could prevent strokes in the population of patients with silent internal carotid artery stenosis and, on the other hand, avoid performing the procedure in the absence of benefit.
PRIMARY ENDPOINTS:
SECONDARY ENDPOINTS:
Creation of a non-invasive computed tomography protocol with pressure gradient assessment in patients with carotid artery stenosis.
A final version of the algorithm based on a new diagnostic measurement (concentration gradient) ready to be used in the diagnosis of CAS-eligible patients with an implemented function for automatic classification of measurement results that will indicate the group of patients who will benefit from the CAS procedure.
After qualification for the study (by a neurologist and vascular surgeon), patients meeting properly the inclusion and exclusion criteria will be referred for imaging studies with Doppler ultrasound, angio-CT scan of the arteries of the neck and head and cerebral perfusion in magnetic resonanse (assessment of the cerebral perfusion alterations using DSC (dynamic susceptibility contrast).
In addition, blood will be drawn and stored for subsequent testing. Afterwards, patients qualified for internal carotid artery angioplasty procedures will receive standard saturation treatment with two antiplatelet drugs (acetylsalicylic acid, clopidogrel) before the procedure, strictly according to the guidelines. The procedures are carried out with approved medical equipment (carotid stent, angioplasty balloon, peripheral neuroprotection). The selection of the appropriate equipment used for the procedure depends on the clinical situation, the experience of the operator and the anatomical conditions of the carotid arteries.
Measurements (invasive pressure in carotid artery) taken during the procedure before angioplasty (after insertion of the neuroprotection into the internal carotid artery) and after stent implantation:
COURSE OF THE STUDY
Baseline examination:
Measurements (invasive pressure) taken during the procedure before angioplasty (after insertion of the neuroprotection into the internal carotid artery) and after stent implantation:
reading the pressure gradient after obtaining a stable value (a minimum of 5 cardiac cycles)
Evaluation during treatment:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with internal carotid stenosis qualified for angioplasty with stent implantation. Standard CAS procedure with additional intravascular pressure measurements
Procedure: CAS + Intravascular measuring the pressure gradient · Procedure: CAS (standard) · Diagnostic Test: Doppler ultrasonound of cephalic arteries · Radiation: Angio-CT of the neck and head · Other: Otolaryngological examination · Other: Psychological examination · Other: Neurological examination · Diagnostic Test: MR cerebral perfusion
Patients with internal carotid stenosis qualified for angioplasty with stent implantation. Standard CAS procedure.
Procedure: CAS (standard) · Diagnostic Test: Doppler ultrasonound of cephalic arteries · Radiation: Angio-CT of the neck and head · Other: Otolaryngological examination · Other: Psychological examination · Other: Neurological examination · Diagnostic Test: MR cerebral perfusion
Measurements taken during the procedure during CAS * placement of a "FFR"- micro catheter on the neuroprotection wire and taking a measurement before the stenosis and in the internal carotid artery above the stenosis * reading the pressure gradient after obtaining a stable value (a minimum of 5 cardiac cycles) * the study of intravascular pressure measurements will be performed using a special micro catheter
Animation of blood pressure measurements on the "FFR" console without actual measurement in carotid artery ("blinding" of the study to the patient) during CAS procedure.
non-invasive assessment of carotid stenosis before surgery and assessment of results after CAS (3 and 12 months after CAS)
Non-invasive pre-operative assessment and post-CAS result (3 months after)
Hearing and balance tests (before and after CAS) - prospective follow-up
psychological examination with questionnaires (before and after CAS) - prospective follow-up
neurological examination with questionnaires (before and after CAS) - prospective follow-up
Assessment of the cerebral perfusion alterations using DSC (dynamic susceptibility contrast) MR perfusion, before and after CAS (after 3 months): Parametric maps of cerebral blood flow (CBF), cerebral blood volume (CBV), time to peak (TTP), and mean transit time (MTT) will be generated and used for the qualitative and quantitative analyses of the following perfusion parameters: * cerebral blood volume (CBV) value in ml/100ml; * cerebral blood flow (CBF) value in ml/100ml/min; * mean transit time (MTT) value in seconds * time to peak (TTP) value in seconds
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on changes in cerebral perfusion after surgery
Composite endpoint including: Assessment of the predictive capabilities of the obtained pressure gradient values * on changes in cerebral perfusion after surgery (assessment of the cerebral perfusion alterations using DSC (dynamic susceptibility contrast) MR perfusion, before and after CAS
Time frame: 3 months
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on neurological status
Composite endpoint including: - changes in neurological status (assesed by the MMSE, mini-mental state examination; NIHSS, National Institutes of Health Stroke Scale),
Time frame: 12 months
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on mental status
Composite endpoint including: - changes in cognitive functions (assesed by the MOCA, Montreal Cognitive Assessment - test)
Time frame: 12 months
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on otolaryngological status in hearing functions
Composite endpoint including: - changes in hearing functions (assesed by the audiometry, tympanometry and ipsilateral middle ear reflex, otoemission, Skarzynski Tinnitus Scale, ABR - Auditory Brainstem Response, BERA)
Time frame: 12 months
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on otolaryngological status in labyrinth functions
Composite endpoint including: - changes in labyrinth functions (assesed by the Skarzynski Tinnitus Scale)
Time frame: 12 months
Predictive capabilities of the obtained invasive pressure gradient in carotid artery stenosis on MACEs after surgery
Composite endpoint including: - occurence of stroke/TIA or death
Time frame: 12 months
Repeatability the diagnostic possibilities of non-invasive tests (Doppler ultrasound) in invasive pressure gradient values
Composite endpoint including: - comparison of the obtained invasive pressure gradient values with Doppler ultrasound (PSV, peak systolic velocity; EDV, end-diastolic velocity; estimated degree of stenosis)
Time frame: 12 months
Repeatability the diagnostic possibilities of non-invasive tests (CT angiogram) in invasive pressure gradient values
Composite endpoint including: - comparison of the obtained invasive pressure gradient values with angio-CT: degree of stenosis
Time frame: 12 months
Repeatability the diagnostic possibilities of non-invasive tests ("CT-FFR") in invasive pressure gradient values
Composite endpoint including: - comparison of the obtained invasive pressure gradient values with "CT-FFR" (planned creation of an algorithm based on test results: invasive pressure gradient, Doppler ultrasound, angio-CT)
Time frame: 12 months
Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (1)
Composite endpoint including: - occurrence of periprocedural neurological event: TIA, stroke, death in patients who underwent CAS with the invasive intravascular pressure measurement procedure
Time frame: 12 months
Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (2)
Composite endpoint including: - occurrence of another periprocedural complication: vascular spasm, perforation, cardiac arrhythmia, hypotonia/hypertension in patients who underwent CAS with the invasive intravascular pressure measurement procedure
Time frame: 12 months
Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (3)
Composite endpoint including: - occurrence of new hypodense (impact) foci in the head CT scan after the procedure in patients who underwent CAS with the invasive intravascular pressure measurement procedure
Time frame: 12 months
Incidence of Treatment-Related Adverse Events [safety and tolerability] associated with the invasive intravascular pressure measurement procedure (4)
Composite endpoint including: - changes (improvement or deterioration) in brain perfusion (see point 1.) in the post-operative examination in patients who underwent CAS with the invasive intravascular pressure measurement procedure
Time frame: 12 months
Algorithm angio-CT/non invasive pressure measurement in carotid
Creation a multiple regression model based on the data from non-invasive pre-procedural measurements on the incidence of unfavourable outcome measures.
Time frame: 48 months
Start is estimated for Apr 2024; primary completion for Jul 2027, 39 months later.
Of 51 non-industry interventional studies with no phase under Carotid Stenosis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 50. This study's planned 39 months is above that.
Counting every sponsor, half of 62 studies reached it within 27 months; a quarter within 19 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
4th Military Clinical Hospital with Polyclinic, Poland